Stocks · Health care · Pharmaceutical Preparations

Generate Biomedicines, Inc.

GENB
United States Fiscal year ends December CIK 0002100782 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Frances Arnold
29 Oct 2026
Director
Sold on a plan
11,409
$16.19
$184.73K
Frances Arnold
1 Sep 2026
Director
Sold on a plan
1,000
$16.00
$16.00K

What was left out

Form 4 filings counted 18
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 67,320,805
History held since 2 Mar 2026